NCT07139067View on ClinicalTrials.gov

Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 27, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2028

Conditions
Advanced Solid Tumor Cancer
Interventions
BIOLOGICAL

YK1101 cells

Drug: Fludarabine + Cyclophosphamide

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Department of GI Oncology, Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142, Beijing

RECRUITING

Peking University Cancer Hospital & Institute, Beijing

All Listed Sponsors
collaborator

Yingkai Saiwei（Beijing）Biotechnology Co., Ltd

UNKNOWN

lead

Peking University

OTHER